Cubist Pharmaceuticals (CBST) reports Q4 revenue of $245.9M (+16% Y/Y) and FY12 revenue at...

|By:, SA News Editor
Cubist Pharmaceuticals (CBST) reports Q4 revenue of $245.9M (+16% Y/Y) and FY12 revenue at $926.4M (+23% Y/Y). (PR)